https://doi.org/10.3389/fmicb.2018.01347
S
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
362
Citations
11
h-index
11
i10-index
Shu Li is an academic researcher from First Affiliated Hospital of Xinxiang Medical University. The author has contributed to research in topics: Antimicrobial Resistance in Staphylococcus & Bacterial biofilms and quorum sensing & Dermatologic Treatments and Research. The author has an h-index of 11, co-authored 19 publications.
ORCID: 0000-0001-9878-0604Papers by this author
worksClinical Staphylococcus argenteus Develops to Small Colony Variants to Promote Persistent Infection
2018 · Frontiers in Microbiology · 32 citations
Deficiency in AK9 causes asthenozoospermia and male infertility by destabilising sperm nucleotide homeostasis
2023 · EBioMedicine · 21 citations
https://doi.org/10.1016/j.ebiom.2023.104798
JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans
2024 · Scientific Reports · 20 citations
https://doi.org/10.1038/s41598-024-67371-5
Corrigendum to “Deficiency in AK9 causes asthenozoospermia and male infertility by destabilising sperm nucleotide homeostasis” [EBioMedicine 96(2023) 104798]
2024 · EBioMedicine · 0 citations
https://doi.org/10.1016/j.ebiom.2023.104957
A Nomogram Predictive Model for Drug-Resistant Tuberculosis Detection by GeneXpert MTB/RIF Assay in Paediatric Patients
2026 · Infection and Drug Resistance · 0 citations
https://doi.org/10.2147/idr.s542863
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat